Indrayani Biotech

Indrayani Biotech

12.72
-0.09
(-0.70%)
ann
There are new updates from the company18 hours ago
Viewcross
right
Market Cap
57.90 Cr
EPS
-1.35
PE Ratio
10.96
Dividend Yield
0.00 %
Industry
FMCG
52 Week High
48.90
52 Week Low
10.20
PB Ratio
0.80
Debt to Equity
1.49
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
neutral
Indrayani Biotech Appoints Ms. Ramya Ravi as Company Secretary & Compliance Officer18 hours ago
Indrayani Biotech Limited appointed Ms. Ramya Ravi as Company Secretary & Compliance Officer effective September 27, 2025. The Board of Directors approved the appointment following the resignation of Mr. V Santhanakrishnan on June 12, 2025. Ms. Ravi is an Associate member of the Institute of Company Secretaries of India with membership number A53694 and has 7 years of experience in secretarial functions. She graduated from MOP Vaishnav College for Women, Chennai, and is not related to any directors of the company.
positive
Indrayani Biotech Limited has received in-principle approval from BSE Limited for a proposed rights issue of partly paid-up equity shares. The approval was granted on September 19, 2025, with reference number LOD/RIGHT/TT/FIP/920/2025-26. The company announced this development through a disclosure signed by Whole-time Director Swaminathan G. The approval relates to BSE's consent for the proposed rights issue under SEBI listing regulations.
positive
Indrayani Biotech Limited announced that its wholly-owned subsidiary, IBL Investments Limited, has received SEBI approval for a Category II Alternative Investment Fund registration. The fund, named IBL INVESTMENT TRUST, has been assigned the registration number IN/AIF2/25-26/1900, effective from September 15, 2025. The approval is perpetual in nature and allows the subsidiary to operate as a SEBI registered Category II Alternative Investment Fund.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
415.75
#1 14,437.00
23.25
#1 8,681.47
12.08
#1 606
8.50
37.97
350.90
8,031.70
14.86
5,655.10
3.17
476
73.90
28.26
1,052.80
5,415.50
17.03
1,251.30
3.28
282
12.36
36.07
105.35
4,832.10
20.37
4,695.10
-7.42
249
-15.25
47.22
361.10
2,166.60
35.56
1,374.20
2.17
61
6.11
59.77
95.02
1,731.70
26.25
1,081.70
-10.58
67
-52.99
63.71
131.50
1,379.90
50.00
361.50
40.17
26
10.81
51.59
266.30
1,324.20
#1 12.98
1,503.90
10.16
103
-4.42
34.39
71.28
1,085.50
19.96
572.20
8.00
48
#1 101.67
39.29
148.13
923.90
32.90
2,024.50
#1 45.63
25
35.05
27.33
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-12.61 %
Cash Flow Change
-287.46 %
ROE
-44.59 %
ROCE
-33.65 %
EBITDA Margin (Avg.)
13.57 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
14
4
5
6
7
14
15
15
17
26
44
46
51
42
41
39
45
32
31
17
53
30
Expenses
14
9
4
7
10
13
13
13
15
23
37
41
46
40
33
36
34
26
26
14
54
26
EBITDA
1
-5
1
-1
-2
1
2
2
2
3
7
5
5
3
7
4
11
6
5
3
-0
5
Operating Profit %
6 %
-159 %
13 %
-20 %
-36 %
7 %
11 %
12 %
13 %
12 %
12 %
12 %
6 %
6 %
18 %
9 %
23 %
19 %
17 %
17 %
-6 %
12 %
Depreciation
0
0
0
0
-0
0
0
0
0
1
1
1
1
1
1
1
1
4
3
2
10
4
Interest
0
0
0
0
1
0
1
1
0
1
1
1
2
2
1
1
6
1
1
1
-2
1
Profit Before Tax
0
-5
0
-2
-3
1
1
1
2
2
5
3
2
-0
6
1
5
1
1
0
-8
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
-5
0
-2
-3
1
1
1
2
2
5
3
1
-0
6
1
5
1
1
0
-9
0
EPS in ₹
0.08
-1.57
0.03
-0.51
-0.92
0.20
0.30
0.33
0.47
0.52
1.47
0.72
0.32
-0.06
0.89
0.22
0.58
0.10
0.13
0.05
-1.42
0.03

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
52
40
51
156
235
268
Fixed Assets
17
15
17
58
62
60
Current Assets
19
9
19
78
145
178
Capital Work in Progress
14
14
13
14
20
26
Investments
0
0
0
0
0
41
Other Assets
21
11
22
85
152
0
Total Liabilities
52
40
51
156
235
268
Current Liabilities
14
12
20
72
87
103
Non Current Liabilities
7
8
7
36
72
66
Total Equity
31
20
25
48
76
73
Reserve & Surplus
-3
-15
-10
10
18
27
Share Capital
4
34
34
44
46
46

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
1
-1
1
2
-3
Investing Activities
-4
-1
-1
-47
-16
Operating Activities
6
0
4
16
-30
Financing Activities
-1
-0
-3
33
44

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
50.39 %
50.39 %
50.39 %
50.17 %
48.81 %
44.91 %
44.89 %
44.89 %
44.89 %
44.89 %
44.84 %
33.63 %
42.13 %
33.57 %
33.48 %
33.40 %
33.28 %
33.28 %
33.28 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
22.04 %
22.04 %
22.04 %
22.04 %
22.04 %
22.04 %
19.17 %
17.16 %
17.03 %
15.27 %
13.11 %
0.00 %
8.47 %
6.75 %
6.79 %
5.59 %
5.25 %
3.66 %
3.11 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.34 %
22.95 %
23.45 %
24.09 %
27.20 %
27.05 %
29.25 %
30.78 %
30.80 %
31.93 %
35.44 %
53.28 %
44.33 %
55.78 %
43.63 %
45.86 %
46.37 %
46.64 %
47.32 %
Others
6.22 %
4.62 %
4.11 %
3.70 %
1.95 %
5.99 %
6.69 %
7.17 %
7.29 %
7.90 %
6.61 %
13.09 %
5.07 %
3.90 %
16.09 %
15.16 %
15.10 %
16.42 %
16.29 %
No of Share Holders
0
18,926
20,362
20,201
20,817
20,925
20,914
22,049
22,112
22,435
22,590
23,034
23,914
23,958
24,132
24,419
25,254
25,126
25,704

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 11.58 12.72
22 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
22 Aug 2024 54.85 49.21
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 45.07 42.10
27 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Feb 2025 27.12 21.74
13 Jun 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Jun 2025 16.14 15.05
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 13.65 12.96

Announcements

Appointment of Company Secretary and Compliance Officer18 hours ago
Closure of Trading Window3 days ago
Receipt Of In-Priniciple Approval7 days ago
Announcement Under Regulation 30 Of SEBI LODR With Regard To Approval Of Category II AIFSep 16, 2025
DISPATCH OF LETTRS TO SHAREHOLDERS UNDER REGULATION 36(1)(B) OF SEBI LODRSep 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 11, 2025
Intimation Of Book Closure Date Under Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 06, 2025
Reg. 34 (1) Annual Report.Sep 06, 2025
Notice Of The 33Rd Annual General Meeting Of The Company Scheduled To Be Held On 29Th September 2025 At 4:00 PM IST Along With The Annual ReportSep 06, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationAug 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 30, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 30Th August 2025 With Regard To Upcoming AGMAug 30, 2025
Board Meeting Intimation for Considering And Approving Draft Notice Of The 33Rd Annual General Meeting.Aug 26, 2025
Board Meeting Outcome for Revised OutcomeAug 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 16, 2025
Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 2025Aug 14, 2025
Board Meeting Outcome for Adoption Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ending June25Aug 14, 2025
Board Meeting Intimation for Adoption Of Unaudited Financial Results For The Quarter Ended June25Aug 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 15, 2025
Outcome Of The Board Meeting Held On 13Th June 2025Jun 13, 2025
Audited Consolidated Financial Results For The Quarter And Year Ended 31St March 2025 Along With Report Of Statutory Auditors.Jun 13, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJun 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th June 2025Jun 12, 2025
Audited Standalone Results For The Quarter And Year Ended 31St March 2025Jun 12, 2025
Board Meeting Intimation for Considering And Approving The Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31St March 2025Jun 09, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesJun 09, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Results-Delay in Financial ResultsMay 27, 2025
Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For Quarter And Year Ended 31St March 2025 To Be Held On 9Th June 2025May 27, 2025
Announcement under Regulation 30 (LODR)-Raising of FundsApr 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 05, 2025
Announcement under Regulation 30 (LODR)-Raising of FundsApr 03, 2025
Appointment Of Dhinakaran Rajagopal As Chief Financial Officer (CFO) Of The CompanyApr 03, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Apr 03, 2025
Outcome Of Board Meeting Held On 3Rd April 2025Apr 03, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd April 2024Apr 03, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 01, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 01, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Apr 01, 2025
Board Meeting Intimation for Considering And Amending The Terms Of Rights Issue Of Equity SharesMar 27, 2025
Closure of Trading WindowMar 26, 2025
Clarification On Consolidated Financial Results Submitted For The Quarter Ended December 31 2025Mar 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 01, 2025
Company PresentationMar 01, 2025
Results-Delay in Financial ResultsFeb 28, 2025

Technical Indicators

RSI(14)
Neutral
53.11
ATR(14)
Volatile
1.17
STOCH(9,6)
Neutral
64.91
STOCH RSI(14)
Overbought
89.08
MACD(12,26)
Bullish
0.19
ADX(14)
Weak Trend
13.86
UO(9)
Bearish
53.83
ROC(12)
Uptrend And Accelerating
4.26
WillR(14)
Neutral
-33.96